CVS Group plc Long Term Incentive Plan Award (5089K)

TIDMCVSG

RNS Number : 5089K

CVS Group plc

05 January 2021

CVS Group Plc

("CVS" or the "Company")

Long Term Incentive Plan Award

CVS, one of the UK's leading providers of integrated veterinary services, announced on 9 November 2020 that it had granted option awards over a total of 136,485 of the Company's ordinary shares of 0.2 pence each ("Ordinary Shares") under the CVS Group Long Term Incentive Plan 2020 ("LTIP 14") (the "Options").

Certain of the awards made have subsequently been adjusted, in accordance with the Group's remuneration policy. The resulting total number of Ordinary Shares over which options have been granted under LTIP14 is now 143,218. Vesting conditions relating to LTIP 14 are unchanged.

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail with regard to the additional award to one Director.

Contacts:

CVS Group Plc Tel: [phone]

Richard Fairman, Chief Executive Juliet Dearlove, Company Secretary

N+1 Singer (Nominated Adviser and Broker) Tel: [phone]

Aubrey Powell (Corporate Finance)

Rachel Hayes (Corporate Broking)

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name               Robin Alfonso 
     -----------------  --------------------------------------------- 
 
 
 
 2     Reason for the notification 
      --------------------------------------------------------------------------- 
 a)    Position/status                    Chief Financial Officer 
      ---------------------------------  ---------------------------------------- 
 b)    Initial notification               Initial Notification 
        /Amendment 
      ---------------------------------  ---------------------------------------- 
 3     Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
      --------------------------------------------------------------------------- 
 a)    Name                               CVS Group plc 
      ---------------------------------  ---------------------------------------- 
 b)    LEI                                213800J41XDQ2NX48O05 
      ---------------------------------  ---------------------------------------- 
 4     Details of the transaction(s): section to be repeated for 
        (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transactions 
        have been conducted 
      --------------------------------------------------------------------------- 
 a)    Description of the financial       Ordinary shares of 0.2 pence each 
        instrument, type of 
        instrument                         GB00B2863827 
 
        Identification code 
      ---------------------------------  ---------------------------------------- 
 b)    Nature of the transaction          Grant of options under LTIP 14 
      ---------------------------------  ---------------------------------------- 
 
 c)    Price(s) and volume(s)              Price(s)                  Volume(s) 
      ---------------------------------   ------------------------  ----------- 
    Exercise price of 
     0.2p                                                            6,733 
   ---------------------------------------------------------------  ----------- 
 d)    Aggregated information 
 
         *    Aggregated volume 
 
 
 
         *    Price 
      ------------------------------------------------------------  ------------- 
 e)    Date of the transaction            Award made on 4 January 2021 
      ---------------------------------  ---------------------------------------- 
 f)    Place of the transaction           Off market 
      ---------------------------------  ---------------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHSSLFWLEFSESF

(END) Dow Jones Newswires

January 05, 2021 02:00 ET (07:00 GMT)